A Rare Cause of Vitamin B12 Deficiency in the Pediatric Age
Daniela Couto, Joana Pereira Mendes, Nuno Lourenço

TL;DR
A 17-year-old refugee in Portugal developed vitamin B12 deficiency due to chronic alcohol use, highlighting the need for awareness in adolescents.
Contribution
This case highlights chronic alcohol use as a rare but important cause of vitamin B12 deficiency in adolescents.
Findings
A 17-year-old adolescent developed vitamin B12 deficiency due to excessive alcohol consumption.
Oral vitamin B12 supplementation was effective in replenishing levels after four months.
The case emphasizes the importance of considering risky behaviors in diagnosing vitamin B12 deficiency in adolescents.
Abstract
Vitamin B12 plays an important role in DNA synthesis, hematopoiesis, and neuronal mechanisms, and its deficiency can be associated with insufficient intake or poor absorption and autoimmune and genetic diseases. Although rare, excessive, and chronic alcohol consumption may also justify a deficiency in this vitamin. We present a case of a 17-year-old Iraqi adolescent refugee in Portugal with a deficiency of vitamin B12 due to excessive and chronic alcohol consumption. Although intramuscular (IM) supplementation with cyanocobalamin is the most used, it was decided to initiate oral supplementation. After four months, vitamin B12 levels were replenished. With this clinical case, we aim to raise awareness of the cause of cyanocobalamin deficiency, which although rare in pediatric age should be considered in adolescents, given the possibility of risky behaviors in this age group.…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
| Initial assessment | Re-evaluation after 4 months | Reference values | |
| Leukocytes | 4.2 x 103/uL | 4.7 x 103/uL | 4.0-10.0 |
| Neutrophils | 1.6 x 103/uL | 2.1 x 103/uL | 1.5-8.0 |
| Lymphocytes | 2.0 x 103/uL | 2.1 x 103/uL | 0.8-4.0 |
| Monocytes | 0.4 x 103/uL | 0.5 x 103/uL | 0.0-1.2 |
| Eosinophils | 0.1 x 103/uL | 0.0 x 103/uL | 0.0-0.3 |
| Basophils | 0.0 x 103/uL | 0.0 x 103/uL | 0.0-0.3 |
| Red blood cells | 4.49 x 106/uL | 4.94 x 106/uL | 4.31-6.40 |
| Hemoglobin | 15.0 g/dL | 16.3 g/dL | 13.6-18.0 |
| Mean corpuscular volume (MCV) | 97.8 fL | 98.9 fL | 80.0-97.0 |
| Mean corpuscular hemoglobin (MCH) | 33.4 pg | 32.9 pg | 26.0-34.0 |
| Red cell distribution width (RDW) | 12.7 % | 12.9 % | 11.5-15 |
| Platelets | 135 x 103/uL | 184 x 103/uL | 140-440 |
| Ferritin | 62 ng/mL | 70.1 ng/mL | 30.0-400.0 |
| Folic acid | 5.8 ng/mL | 5.2 ng/mL | >3.9 |
| Vitamin B12 | 90.3 pg/mL | 329.9 pg/mL | 197.0-771.0 |
| Aspartate aminotransferase (AST) | 16 U/L | 15 U/L | 0-38 |
| Alanine aminotransferase (ALT) | 10 U/L | 9 U/L | 0-41 |
| Lactate dehydrogenase (LDH) | 155 U/L | 125-220 | |
| Gamma-glutamyl transferase (GGT) | 8 U/L | 13 U/L | 7-66 |
| Alkaline phosphatase | 69 U/L | 40-129 | |
| Total proteins | 7.4 g/dL | 6.4-8.3 | |
| Albumin | 4.7 g/dL | 3.2-4.5 | |
| Thyroid-stimulating hormone (TSH) | 1.85 uUI/mL | 0.51-4.30 | |
| Free thyroxine (T4) | 1.07 ng/dL | 0.98-1.63 | |
| Anti-parietal cell antibodies | Doubtful | ||
| Anti-intrinsic factor antibodies | Negative | ||
| Anti-transglutaminase IgA antibodies | 3.6 U/mL | 0.8-10.0 | |
| Anti-transglutaminase IgG antibodies | 0 U/mL | 0.0-10.0 |
| Type | Clinical manifestations |
| Hematological | Anemia (macrocytic, megaloblastic), leukopenia, thrombocytopenia, pancytopenia, thrombocytosis |
| Neuropsychiatric | Cognitive impairment, dementia, depression, gait abnormalities, irritability, olfactory impairment, peripheral neuropathy |
| Gastrointestinal | Glossitis |
| Cutaneous | Hyperpigmentation, jaundice, vitiligo |
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsFolate and B Vitamins Research · Porphyrin Metabolism and Disorders · Metabolism and Genetic Disorders
Introduction
Vitamin B12 plays an important role in DNA synthesis, hematopoiesis, and neuronal mechanisms [1]. Its deficiency can be associated with insufficient intake or poor absorption, excessive and chronic alcohol consumption, and autoimmune and genetic diseases [2,3]. Treatment consists of supplementation with oral, intramuscular (IM), or nasal cyanocobalamin. Despite the IM route being frequently used, literature data show that oral supplementation is equally effective and is associated with lower costs [4,5].
Case presentation
A 17-year-old adolescent, Iraqi, institutionalized, and a refugee in Portugal for two years, is being followed up in a Pediatric Psychiatry consultation for posttraumatic stress disorder with associated behavior alteration including episodes of heteroaggressiveness and persecutory speech. He is being treated with olanzapine and alprazolam and has a history of therapeutic noncompliance and multiple missed hospital consultations. An evaluation was requested in the General Pediatrics consultation due to macrocytosis, thrombocytopenia, and vitamin B12 deficiency found in a routine analytical study (Table 1).
During the first appointment, the adolescent denied gastrointestinal alterations, weight loss, paraesthesia, tremors, or focal neurological deficits. He reported maintaining a varied diet, not vegan/nonvegetarian, only restricting pork consumption. He had no surgical history. He admitted to starting tobacco and alcohol consumption at the age of seven, sometimes drinking a bottle of whiskey per day. Currently, he drinks a few shots of whiskey per week and two beers per day. He smokes about five cigarillos per day. He denied using other drugs or exposure to lithium. Upon objective examination, thinness and muscular atrophy were observed. Mucous membranes were colored. No hyper- or hypopigmented skin patches were observed. No palpable lymphadenopathy. No hepatosplenomegaly. A brief neurological examination, including osteotendinous reflexes, was normal.
A new analytical study was conducted to exclude celiac disease and pernicious anemia. Given the history of multiple missed hospital consultations, it was decided to start oral supplementation with vitamin B12 (1 mg, once a day), and the need to stop alcohol consumption was explained.
The adolescent was re-evaluated four months later, with vitamin B12 levels replenished, no changes in the blood count, no other vitamin deficiencies, and a negative celiac disease screening, negative anti-intrinsic factor antibody, and questionable anti-parietal cell antibody (Table 1). He had no new symptoms, and he maintained the earlier neuropsychiatric manifestations. In addition, he admitted to continuing alcohol consumption, about 140 g of ethanol per week. It was decided to continue supplementation for a period of three months with subsequent analytical re-evaluation. The adolescent missed subsequent appointments, refusing to continue follow-up.
Discussion
Vitamin B12 is present in most animal-derived products, and although its deficiency is more commonly observed in adults, it can also occur in pediatric age [1]. It can result from inadequate intake or diminished absorption, autoimmune diseases, genetic disorders, and some medications. It is important to note that the drugs the teenager was taking, despite causing sedation, xerostomia, dizziness, and changes in appetite, do not cause a vitamin B12 deficiency [1,2]. In addition, smoking is not a direct cause of vitamin B12 deficiency, but eating habits with less balanced diets can contribute to an increased risk of nutrient deficiency [6].
Although rare, excessive and chronic alcohol consumption may also justify a deficiency in this vitamin. Alcohol interferes with erythropoiesis and the digestion, storage, utilization, and excretion of nutrients [7]. Literature shows that chronic alcohol consumption decreases the absorption of vitamins either by direct damage to stomach and intestinal cells or by inhibiting pancreatic enzymes necessary for the absorption of these elements [8,9]. Moreover, the vitamin deficiency present in these individuals may also be justified by inadequate nutritional intake, as they tend to neglect a balanced and varied diet.
Although this diagnostic hypothesis is the most likely in this clinical case, a study was conducted to exclude pernicious anemia. Indeed, pernicious anemia is one of the main causes of vitamin B12 deficiency. It is an autoimmune disease, where the production of antibodies against intrinsic factors and/or parietal cells prevents the absorption of this vitamin [10]. Although anti-parietal cell antibody was questionable and not specific to pernicious anemia in clinical practice [10], it was decided to conduct a new analytical re-evaluation, but the adolescent did not attend and refused to continue follow-up, thus hindering further evaluation and monitoring.
Clinical manifestations can be relatively nonspecific (Table 2), and it is important to note that although the adolescent was asymptomatic at the first consultations, the deficiency of this vitamin may also explain his neuropsychiatric alterations.
In case of adolescents and adults, the preferred treatment consists of IM supplementation. Additionally, this route is more commonly used in cases of severe anemia, neurological alterations, or compromised absorption, such as in pernicious anemia [4]. However, literature data reveal that the oral route is not inferior to IM administration, has no more adverse effects, and is preferred by patients [11-13]. It is important to mention that some of these studies have limitations, including the use of different administration schemes and doses, short follow-up times, and small samples, with most subjects being above 18 years old, which may explain the limited use of this route in clinical practice [5,9]. A review conducted by Cochrane in 2018, acknowledging the limitations, shows that oral supplementation is equally effective, reducing the need for patient visits to hospitals and associated costs [5].
Conclusions
Vitamin B12 deficiency can be associated with multiple causes. Given the future consequences such as hematological alterations or neurological impairment, it is essential to make appropriate diagnosis and treatment. With this clinical case, we aim to raise awareness of a cause of cyanocobalamin deficiency, which although rare in pediatric age, should be considered in adolescents, given the possibility of risky behaviors in this age group. Lastly, it is worth emphasizing that given the therapeutic options, we have found that oral administration of vitamin B12 has been effective, as reported in the literature.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Nelson Textbook of Pediatrics. 21st Edition Kliegman R St Geme J Philadelphia (PA)Elsevier Inc.2020
- 2Causes and pathophysiology of vitamin B 12 and folate deficiencies Upto Date 5 2023 Means Means R.R. Fairfield Fairfield KK 2022 https://www.uptodate.com/contents/causes-and-pathophysiology-of-vitamin-b 12-and-folate-deficiencies
- 3Clinical manifestations and diagnosis of vitamin B 12 and folate deficiency Clinical manifestations and diagnosis of vitamina 5 2023 Means R Fairfield K 2023122023 https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-vitamin-b 12-and-folate-deficiency
- 4Treatment of vitamin B 12 and folate deficiencies Up To Date 5 2023 Means R Fairfield K 2023 https://www.uptodate.com/contents/treatment-of-vitamin-b 12-and-folate-deficiencies
- 5Oral vitamin B(12) versus intramuscular vitamin B(12) for vitamin B(12) deficiency Cochrane Database Syst Rev Wang H Li L Qin LL Song Y Vidal-Alaball J Liu TH 03201810.1002/14651858.CD 004655.pub 3PMC 649418329543316 · doi ↗ · pubmed ↗
- 6Effect of cigarette smoking on serum homocysteine and vitamin B 12 level in male population of Udaipur Biochem Anal Biochem Deepa Singh 252016
- 7Functional vitamin B 12 deficiency in alcoholics: an intriguing finding in a retrospective study of megaloblastic anemic patients Eur J Intern Med Fragasso A Mannarella C Ciancio A Sacco A 971002120102020687910.1016/j.ejim.2009.11.012 · doi ↗ · pubmed ↗
- 8National Institute on Alcohol Abuse and Alcoholism Alcoholism No. 22 PH 346 October 1993 https://www.niaaa.nih.gov/
